PE20010990A1 - A KIT THAT INCLUDES AS A FIRST COMPONENT IRINOTECHANE OR A COMPOSITION THAT INCLUDES IRINOTECHANE AND AS A SECOND COMPONENT ONE OR SEVERAL DOSES OF CARBON - Google Patents
A KIT THAT INCLUDES AS A FIRST COMPONENT IRINOTECHANE OR A COMPOSITION THAT INCLUDES IRINOTECHANE AND AS A SECOND COMPONENT ONE OR SEVERAL DOSES OF CARBONInfo
- Publication number
- PE20010990A1 PE20010990A1 PE2000001409A PE0014092000A PE20010990A1 PE 20010990 A1 PE20010990 A1 PE 20010990A1 PE 2000001409 A PE2000001409 A PE 2000001409A PE 0014092000 A PE0014092000 A PE 0014092000A PE 20010990 A1 PE20010990 A1 PE 20010990A1
- Authority
- PE
- Peru
- Prior art keywords
- irinotechane
- component
- carbon
- kit
- composition
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title abstract 3
- 229910052799 carbon Inorganic materials 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- CZVTYGFISHLVHK-UHFFFAOYSA-N 4h-pyran-2,3-dione Chemical compound O=C1CC=COC1=O CZVTYGFISHLVHK-UHFFFAOYSA-N 0.000 abstract 1
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003610 charcoal Substances 0.000 abstract 1
- 239000003245 coal Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE AL USO DE CARBON PARA EVITAR O ALIVIAR DIARREA TARDIA INDUCIDA POR IRINOTECANO SAL CLORHIDRATO (S)-4,[1-DIETIL-3,4,12,14-TETRAHIDRO-4-HIDROXI-3,14,DIOXO-1H-PIRANO[3',4':6,7]-INDOLIZINO[1,2-b]QUINOLIN-9-IL ESTER DEL ACIDO 11,4'-BIPIPERIDINA]-1'-CARBOXILICO); CARACTERIZADO PORQUE EL CARBON SE ADMINISTRA EN FORMA DE SUSPENSION ACUOSA DE CARBON DE LENA. TAMBIEN SE REFIERE A UN KIT QUE CONTIENE UN COMPONENTE: IRINOTECANO; UNA COMPOSICION QUE CONTIENE IRINOTECANO, CARBONREFERS TO THE USE OF CARBON TO AVOID OR RELIEVE LATE DIARRHEA INDUCED BY IRINOTECHANE SALT HYDROCHLORATE (S) -4, [1-DIETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14, DIOXO-1H- PYRANE [3 ', 4': 6.7] -INDOLYZINE [1,2-b] QUINOLIN-9-IL ESTER OF 11,4'-BIPIPERIDINE] -1'-CARBOXYL ACID); CHARACTERIZED BECAUSE COAL IS ADMINISTERED IN THE FORM OF A WATERY SUSPENSION OF CHARCOAL FROM LENA. IT ALSO REFERS TO A KIT CONTAINING A COMPONENT: IRINOTECHANE; A COMPOSITION CONTAINING IRINOTECHANE, CARBON
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002295429A CA2295429A1 (en) | 2000-01-06 | 2000-01-06 | Treatment or prevention of diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010990A1 true PE20010990A1 (en) | 2001-09-22 |
Family
ID=4165060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001409A PE20010990A1 (en) | 2000-01-06 | 2000-12-28 | A KIT THAT INCLUDES AS A FIRST COMPONENT IRINOTECHANE OR A COMPOSITION THAT INCLUDES IRINOTECHANE AND AS A SECOND COMPONENT ONE OR SEVERAL DOSES OF CARBON |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR026791A1 (en) |
| AU (1) | AU2335601A (en) |
| CA (1) | CA2295429A1 (en) |
| PE (1) | PE20010990A1 (en) |
| WO (1) | WO2001049299A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013534A2 (en) * | 2001-07-23 | 2003-02-20 | Epidauros Biotechnologie Ag | Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| WO2004103371A1 (en) * | 2003-05-21 | 2004-12-02 | Pharmacia & Upjohn Company Llc | Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1003516A4 (en) * | 1998-06-18 | 2006-07-12 | Univ George Washington | METHOD FOR THE ADMINISTRATION OF CAMPTOTHECIN COMPOSITIONS FOR CANCER TREATMENT WITH REDUCED SIDE EFFECTS |
| CA2340020A1 (en) * | 1998-08-05 | 2000-02-17 | Aventis Pharma S.A. | Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| WO2001052828A2 (en) * | 2000-01-18 | 2001-07-26 | University Of Massachusetts | Glutamine prevention of delayed-onset irinotecan-induced diarrhea |
-
2000
- 2000-01-06 CA CA002295429A patent/CA2295429A1/en not_active Abandoned
- 2000-12-21 WO PCT/CA2000/001544 patent/WO2001049299A2/en not_active Ceased
- 2000-12-21 AU AU23356/01A patent/AU2335601A/en not_active Abandoned
- 2000-12-28 PE PE2000001409A patent/PE20010990A1/en not_active Application Discontinuation
-
2001
- 2001-01-04 AR ARP010100029A patent/AR026791A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2335601A (en) | 2001-07-16 |
| WO2001049299A3 (en) | 2002-02-21 |
| CA2295429A1 (en) | 2001-07-06 |
| AR026791A1 (en) | 2003-02-26 |
| WO2001049299A2 (en) | 2001-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2330727T3 (en) | KAPPA OPIOID RECEIVER LIGANDS. | |
| AR034985A1 (en) | BICYCLE COMPOUND; PRODUCTION AND USE OF THE SAME | |
| SV2002000195A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS REF. PCS10342 AFAE / BB | |
| AR108955A2 (en) | CRYSTAL REBAMIPIDA WATERPROOF OPTICAL SUSPENSION | |
| AR031830A1 (en) | USE OF A BENZOTIAZINONE OR BENZOXAZINONE COMPOUND TO PREPARE A PHARMACEUTICAL COMPOSITION, BENZOTIAZINONE OR BENZOXAZINONE COMPOSITE AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| PE20090840A1 (en) | SMALL MOLECULES CONTAINING BORON | |
| PE20020228A1 (en) | ORGANIC COMPOUNDS AS INHIBITORS OF 3 ', 5' GUANOSIN CYCLIC MONOPHOSPHATE PHOSPHODIESTERASE | |
| BRPI0412347A (en) | 2-Aminophenyl-4-phenylpyridines as kinase inhibitors | |
| PE20040946A1 (en) | PYRAZOLOTRIAZINE COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | |
| PE20060921A1 (en) | PROCEDURE TO PREPARE CHIRAL 8- (3-AMINO-PIPERIDIN-1-IL) -XANTHINES | |
| DE50302975D1 (en) | NEW XANTHINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DRUGS | |
| BRPI0517423A (en) | compound, pharmaceutical composition, method for treating or preventing neurological and psychiatric disorders associated with glutamate dysfunction in an animal, and, use in a compound | |
| UY28132A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
| PE20040937A1 (en) | DERIVATIVES OF PYRIDAZIN-3 (2H) -ONE AS INHIBITORS OF PHOSPHODIESTERASE-4 (PDE 4) | |
| PE20050948A1 (en) | CARBAMOIL-AMINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | |
| EA200201271A1 (en) | INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1 | |
| AR025739A1 (en) | NEW BENCIMIDAZOLON DERIVATIVES THAT HAVE AFFINITY FOR MIXED SEROTONINE AND DOPAMINE RECEIVERS | |
| ECSP077402A (en) | DERIVATIVES OF 2-AMIDO-4-PHENYLTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
| CO5680438A2 (en) | USE OF CYCLLOTIOCARBAMATE DERIVATIVES IN TREATMENT OF CONDITIONS RELATED TO HORMONES | |
| PE20070793A1 (en) | TRICYCLIC COMPOUNDS CONTAINING NITROGEN AS ANTIBACTERIAL AGENTS | |
| AR115411A2 (en) | 8- [3-AMINO-PIPERIDIN-1-IL] -XANTHINES AS INHIBITORS OF DPP-IV | |
| TW200603799A (en) | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | |
| NZ603792A (en) | Modulators of 5-ht receptors and methods of use thereof | |
| AR086573A2 (en) | DERIVATIVES OF 5- (PIRIDIN-3-IL) -1-AZABICICLO [3,2,1] OCTANO AND OCTENO, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
| ECSP066992A (en) | ACID 2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONYL] AMINO} -3- (PHENYLPIRIDIN-2-ILAMINO) PROPERLY PURELY INHIBITOR OF THE IKB KINASE INHIBITOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |